| Original language | English (US) |
|---|---|
| Pages (from-to) | 109-121 |
| Journal | Cancer Translational Medicine |
| Volume | 3 |
| Issue number | 4 |
| State | Published - 2017 |
SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models
- Jeremy Hengst
- , Taryn E. Dick
- , Arati Sharma
- , Kenichiro Doi
- , Shailaja Hegde
- , Su Fern Tan
- , Laura Geffert
- , Todd E. Fox
- , Arun K. Sharma
- , Dhimant Desai
- , Shantu Amin
- , Mark Kester
- , Thomas P. Loughran
- , Robert Paulson
- , David Claxton
- , Hong-Gang Wang
- , Jong Yun
- Penn State Cancer Institute
- Cancer Institute, Next-Generation Therapies
- Cancer Institute, Mechanisms of Carcinogenesis
- Huck Institutes of the Life Sciences
- Veterinary and Biomedical Sciences
- Department of Medicine
- Department of Pediatrics
- Division of Hematology and Oncology
- Division of Hematology and Oncology
- Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
- Penn State Neuroscience Institute
- Department of Molecular and Precision Medicine
- Department of Cell and Biological Systems
- Department of Neuroscience and Experimental Therapeutics
Research output: Contribution to journal › Article › peer-review